SCHEMBL2984532

SCHEMBL2984532

CCC(O)c1ccc(O)cc1O

nearest known ligand 0.56

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ TYR P14679 4/20 0.47
▸ PDE2A O00408 1/20 0.43
▸ HSP90AB1 P08238 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12610365 1.00 TYR (0.47) TYRPDE2AHSP90AB1
SCHEMBL2987382 0.83 ADRA2A (0.43) TYRPDE2A
SCHEMBL11138508 0.82 LMNA (0.59) PDE2A
SCHEMBL28957756 0.81 TYR (0.59) TYR
SCHEMBL31544892 0.81 LMNA (0.50) TYRHSP90AB1
SCHEMBL21830477 0.81 TYR (0.48) TYRHSP90AB1
SCHEMBL29492305 0.81 TYR (0.48) TYRHSP90AB1
SCHEMBL7149125 0.81 TAAR1 (0.54) —
SCHEMBL5439730 0.81 TYR (0.53) TYRHSP90AB1
SCHEMBL9660619 0.81 TYR (0.44) TYR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7777073-B2 Topical delivery system for antiaging and skin whitening agents BIODERM RESEARCH (US) 2010-08-17 — — US disclosed
US-20090074691-A1 Topical Delivery System for Antiaging and Skin Whitening Agents BIODERM RESEARCH (US) 2009-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090074691-A1 Topical Delivery System for Antiaging and Skin Whitening Agents TYR, MMP17, MMP1 TYR 1/4885PDE2A 1637/4885HSP90AB1 1164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback